Difference between revisions of "Epidermal growth factor receptor inhibitors"
Jump to navigation
Jump to search
(+cancer drugs) |
(→Use) |
||
| Line 10: | Line 10: | ||
==Use== | ==Use== | ||
*[[Lung adenocarcinoma]]. | *[[Lung adenocarcinoma]]. | ||
**[[Lung carcinoma with EGFR rearrangement]]. | |||
*[[Colorectal adenocarcinoma]]. | *[[Colorectal adenocarcinoma]]. | ||
*[[Cancer drugs]]. | *[[Cancer drugs]]. | ||
Revision as of 17:43, 18 June 2017
Epidermal growth factor receptor inhibitors, abbreviated EGFR inhibitors, is a class of drugs that blocks the EGF receptor.
Drugs
Note:
- Both gefitinib and erlotinib are also classified as tyrosine kinase inhibitors (TKIs).